Immunology

Injectable HIV ART Is an Effective Alternative to Oral Medications

February 22, 2024 - On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at suppressing human immunodeficiency virus (HIV) replication in patients who could not achieve or maintain viral suppression with oral...

Read More


More Articles

Novo Nordisk Launches Vaccine Initiative for Airborne Infections

by Veronica Salib

In an announcement published on December 18, 2023, Novo Nordisk, headquartered in Copenhagen, Denmark, announced its plans to allocate $260 million to research and develop vaccines for airborne...

Nektar Sues Eli Lilly for Incorrect Clinical Trial Results

by Hayden Schmidt

On Monday, Nektar Therapeutics released a scathing public statement that accused its former partner, Eli Lilly, of miscalculating and sharing clinical trial results that underrepresented the...

Eli Lilly Announces $2.4B Acquisition of Immunology Company Dice Therapeutics

by Hayden Schmidt

Monday, Eli Lilly announced that it would acquire Dice Therapeutics for $2.4 billion in cash, representing a 40% premium on the recent trading value of the smaller firm. Lilly’s purchase...

Merck Plans to Acquire Prometheus Biosciences in a $10.8 Billion Deal

by Veronica Salib

On April 16, 2023, Merck announced plans to expand its immunology portfolio by acquiring Prometheus Biosciences, a biotechnology company focused on immune-mediated diseases. The deal, valued at $10.8...

Cleveland Clinic Enrolls Patients in Breast Cancer Vaccine Trial

by Veronica Salib

The Cleveland Clinic recently announced that it would begin enrolling patients for its phase 1b breast cancer vaccine study. The study will focus on cancer-free patients at risk of developing cancer,...

From COVID to Cancer, Understanding the Applications of mRNA Vaccines

by Veronica Salib

Throughout the COVID-19 pandemic, patients, researchers, and providers became increasingly familiar with mRNA vaccines, which have unparalleled public health benefits. While mRNA vaccines have been researched for years, the rapid...

Developing Next-Generation COVID Vaccines, an Urgent Need

by Veronica Salib

As the COVID pandemic has progressed, the healthcare industry has seen the virus and the state of the pandemic evolve. Equipped with the available vaccines and treatments, providers and other...

COVID-19 Vaccine Side Effects Are Associated with Antibody Response

by Veronica Salib

As with any vaccine, the COVID-19 vaccine led to some common side effects. However, the severity of these side effects varies by individual. In a recent study published in JAMA Network Open,...

NIH Awarded Intravacc $14.6 Million to Develop a Gonorrhea Vaccine

by Veronica Salib

Gonorrhea is one of the most common bacterial infections and is the third most common sexually transmitted infection (STI) in the United States. In an effort to mitigate disease spread, the NIH’s...

How Antirejection Drugs Can Promote Successful Transplants

by Veronica Salib

The United Network for Organ Sharing (UNOS) states that, as of July 2022, there have been 24,414 organ transplants this year in the United States alone. Considering the limitations on the number of organs available for transplant and the...

Orexo Pharmaceuticals Announces Nasal Adrenaline Clinical Development

by Veronica Salib

On July 5, 2022, Orexo Pharmaceuticals announced plans to begin clinical development of a nasal adrenaline rescue medication. This study, called OX640-001, is looking at OX640, which is a nasal...

Pfizer-BioNTech’s Expanding Coronavirus Vaccine FDA Approval

by Hayden Schmidt

Late last month, Pfizer announced its coronavirus vaccine clinical trial results, indicating that a three-dose regimen of the Pfizer-BioNTech vaccine was safe and effective for children older than 6...

Recent Articles